Stage FocusSeed, Series A
GeographyUS
TypeVC
Last Activity2025
Industry Focus
Industries
BiotechSynthetic BiologyMedtech
Technical BenchStrong
Investor TypeDeepTech Purist
ExposureMostly DeepTech Investments
Bio
Atlas Venture has been running for over 30 years and is one of the world's leading biotech-only VCs. The firm operates a two-fund model: Fund XIV ($450M, closed December 2024) for seed and Series A, and Opportunity Fund III ($400M, closed September 2025) for growth-stage follow-on.
The company-building track record is substantial — 78 startups launched through the incubator, with 42 IPOs and 37 M...
Notable Investments
A
Alnylam PharmaceuticalsK
Kymera TherapeuticsN
Nimbus TherapeuticsP
Prime MedicineC
Chroma MedicineSimilar Funds
AV
Alix Ventures
San Francisco, United States
Pure DeepTechBiotechSynthetic BiologyMedtechPre-SeedSeed
ARCH Venture Partners
Chicago, United States
Pure DeepTechBiotechMedtechSynthetic BiologySeedSeries A
MB
Mission Bay Capital
San Francisco, United States
Pure DeepTechBiotechMedtechSynthetic BiologySeedSeries A
PS
Panacea Stars
Oxford, United Kingdom
Pure DeepTechBiotechAIMedtechPre-SeedSeed
Third Rock Ventures
Boston, United States
Pure DeepTechBiotechMedtechSynthetic BiologySeedSeries A
3B
3E Bioventures Capital
China
Pure DeepTechBiotechMedtechSeedSeries A